1. Home
  2. OMDA vs DRTS Comparison

OMDA vs DRTS Comparison

Compare OMDA & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OMDA

Omada Health Inc.

HOLD

Current Price

$22.99

Market Cap

978.5M

Sector

Health Care

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$13.32

Market Cap

978.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMDA
DRTS
Founded
2011
2015
Country
United States
Israel
Employees
943
121
Industry
Medical/Nursing Services
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
978.5M
978.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OMDA
DRTS
Price
$22.99
$13.32
Analyst Decision
Buy
Strong Buy
Analyst Count
11
3
Target Price
$21.73
$8.67
AVG Volume (30 Days)
1.1M
784.7K
Earning Date
05-07-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.96
N/A
Revenue Next Year
$20.08
$699.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.28
$2.87
52 Week High
$26.92
$14.11

Technical Indicators

Market Signals
Indicator
OMDA
DRTS
Relative Strength Index (RSI) 62.92 62.09
Support Level $14.39 $6.59
Resistance Level $26.46 $14.11
Average True Range (ATR) 1.00 0.93
MACD -0.11 0.00
Stochastic Oscillator 39.23 67.44

Price Performance

Historical Comparison
OMDA
DRTS

About OMDA Omada Health Inc.

Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: